Tag
Lose fat
50 posts tagged “Lose fat”.
Orforglipron: A Tracking Guide for an Oral Small-Molecule GLP-1
A measured, harm-reduction look at orforglipron, a non-peptide GLP-1 pill approved for obesity, and what actually matters to track.
Oral Semaglutide 25 mg: A Tracking Guide for the Wegovy Pill
A neutral, harm-reduction guide to the oral semaglutide weight-management pill, its strict dosing rules, and what to monitor.
CagriSema: A Tracking Guide for a Cagrilintide and Semaglutide Combination
A harm-reduction look at CagriSema, an investigational amylin-plus-GLP-1 combination not yet approved, and what would be worth tracking.
Mazdutide: A Tracking Guide for a Glucagon and GLP-1 Dual Agonist
A neutral, harm-reduction guide to mazdutide, a dual glucagon/GLP-1 agonist approved in China, and what to monitor.
Survodutide: A Tracking Guide for a GLP-1 and Glucagon Dual Agonist
A harm-reduction look at survodutide, an investigational GLP-1/glucagon agonist with obesity and MASH data, not yet approved.
Cardarine (GW-501516): A Tracking Guide for a PPAR-Delta Agonist
A candid, harm-reduction look at cardarine, its endurance and fat-oxidation effects, and the rodent carcinogenicity signal that ended its development.
Amycretin: A Tracking Guide for a GLP-1 and Amylin Agonist
A neutral, harm-reduction guide to amycretin, an investigational GLP-1/amylin agonist in oral and injectable forms, entering Phase 3.
Andarine (S4): A Tracking Guide for an Older Cutting SARM
A harm-reduction look at andarine, its use in cutting phases, and the reversible vision side effect that sets it apart from other SARMs.
VK2735: A Tracking Guide for a GIP and GLP-1 Dual Agonist
A harm-reduction look at VK2735, an investigational GIP/GLP-1 agonist in oral and injectable Phase 3 programs, not yet approved.
Pemvidutide: A Tracking Guide for a GLP-1 and Glucagon Agonist
A neutral, harm-reduction guide to pemvidutide, an investigational GLP-1/glucagon agonist noted for lean-mass sparing and MASH data.
Stenabolic (SR9009): A Tracking Guide for a REV-ERB Exercise Mimetic
A harm-reduction look at SR9009, its exercise-mimetic claims, and the poor oral bioavailability that undercuts most real-world use.
Bimagrumab: A Tracking Guide for an Activin Receptor Antibody
A harm-reduction look at bimagrumab, an investigational antibody that lowers fat while preserving or adding muscle, studied with semaglutide.
Clenbuterol: A Harm-Reduction Tracking Guide for a Beta-2 Agonist
A cautious, harm-reduction look at clenbuterol, a stimulant thermogenic with real cardiac risk, and what to monitor if you have already decided to use it.
T3 (Liothyronine): A Tracking Guide for a Synthetic Thyroid Hormone
A measured look at liothyronine (T3), why it is used for fat loss, and the muscle and cardiac risks that come with suppressing your own thyroid.
DNP (2,4-Dinitrophenol): A Harm-Reduction Tracking Guide for a Dangerous Uncoupler
A blunt harm-reduction guide to DNP, a mitochondrial uncoupler with a narrow margin between fat loss and death, for people who have already obtained it.
Testosterone Enanthate: A Tracking Guide for a Long-Ester Androgen
A measured, harm-reduction look at testosterone enanthate, what to monitor on TRT or a cycle, and the bloodwork that actually matters.
Testosterone Cypionate: A Tracking Guide for TRT and Beyond
Cypionate behaves almost identically to enanthate. Here is what to monitor, the bloodwork that matters, and the mistakes to avoid.
Testosterone Propionate: A Tracking Guide for the Short Ester
Propionate clears fast, which means frequent injections and sharper fluctuations. Here is what that changes about tracking.
Sustanon 250: A Tracking Guide for the Testosterone Blend
A four-ester testosterone blend with a tricky release curve. Why the mixed esters complicate tracking and what to monitor.
Trenbolone Enanthate: A Tracking Guide for a High-Risk Anabolic
A potent 19-nor anabolic with a heavy side-effect load. This is a harm-reduction tracking guide, not an endorsement.
Trenbolone Acetate: A Tracking Guide for the Fast-Acting Variant
Same potent, high-risk compound as the enanthate version, on a short ester. What the faster clearance changes for tracking.
Drostanolone Propionate (Masteron): A Tracking Guide for the Short Ester
A DHT-derived anabolic associated with cutting and "hardening." What that means, what it does not do, and what to monitor.
Drostanolone Enanthate: A Tracking Guide for the Long-Ester Masteron
The longer-acting version of Masteron. Same DHT-derived profile, fewer injections, slower kinetics. What to track.
Methenolone Enanthate (Primobolan): A Tracking Guide for a "Mild" Anabolic
Often called gentle, but still suppressive and not risk-free. What "mild" actually means and what to monitor.
Oxandrolone (Anavar): A Tracking Guide for a Mild Oral Anabolic
An oral with a real medical history and a gentle reputation - but real liver, lipid, and suppression concerns. What to monitor.
Stanozolol (Winstrol): A Tracking Guide and Lipid Warning
A DHT-derived steroid known for a "dry" look - and for hammering cholesterol and joints. What to monitor closely.
5-Amino-1MQ: A Tracking Guide for an NNMT Inhibitor
What 5-Amino-1MQ is, why it is studied as a metabolic compound, and how a self-experimenter can structure tracking around very limited human data.
CJC-1295 with DAC: Tracking the Long-Acting GHRH Analog
A practical tracking guide for the DAC version of CJC-1295, with weekly dosing rationale and IGF-1 expectations.
Ipamorelin: A Standalone Tracking Guide
A pragmatic log structure for ipamorelin used on its own, separate from the common CJC-1295 stack.
CJC-1295 No-DAC (Mod GRF 1-29): Pulsatile GHRH Tracking
How the short-acting GHRH analog works, why it mimics natural GH pulses, and what to track when using it.
AOD-9604: A Tracking Guide for an hGH Fragment
What AOD-9604 is, why it failed in obesity trials, and how to track fat-loss protocols if you choose to use it.
CJC-1295 No-DAC + Ipamorelin Pre-Blend: Practical Tracking
What to know about using a pre-mixed CJC-1295/ipamorelin blend versus separate vials, and how it affects your tracking.
Metformin: The Old Drug in the Longevity Conversation
A tracking guide for metformin that takes its prescription status and side effects seriously.
Dulaglutide (Trulicity): A Practical Tracking Guide
Weekly GLP-1 receptor agonist with a clean titration shape — what to track and how it compares to semaglutide and tirzepatide.
Sermorelin: Tracking the Full-Length GHRH Analog
A tracking guide for sermorelin, the 29-amino-acid GHRH analog, with realistic expectations for sleep, recovery, and IGF-1 changes.
MOTS-c: A Mitochondrial Peptide With Real Biology and Modest Human Data
What MOTS-c does, what it might do in humans, and how to track it honestly.
Tirzepatide: A Tracking Guide for the Dual GLP-1 / GIP Titration
A focused guide to tracking a tirzepatide protocol — the titration, the unique GIP-side effects, sulfur burps, and what to log week-over-week.
Sermorelin / Ipamorelin Blends: What the Pre-Mix Actually Costs You
A practical look at pre-mixed sermorelin/ipamorelin blends — the GHRH plus GHRP rationale and the tracking tradeoffs of using one syringe.
Tracking Semaglutide: Dose Titration and Side Effects
A pragmatic guide to logging a semaglutide titration. What to capture daily, weekly, and at every dose increase.
Exenatide (Byetta and Bydureon): Tracking the Original GLP-1
The first-in-class GLP-1 receptor agonist, derived from Gila monster venom — twice-daily and weekly versions tracked.
L-Carnitine: A Tracking Guide for Energy and Fat Oxidation
How to log L-carnitine use across oral, injectable, and IV protocols with realistic expectations.
Somatropin (HGH): A Tracking Guide with Serious Safety Emphasis
A careful tracking guide for recombinant human growth hormone, focused on what to monitor when using a prescription compound with real metabolic consequences.
GHRP-2: Tracking a Classic GH Secretagogue
A practical tracking guide for GHRP-2, a ghrelin mimetic often paired with GHRH analogs, with attention to cortisol and prolactin.
Cagrilintide: A Tracking Guide for a Long-Acting Amylin Analog
What cagrilintide is, why it is being studied with semaglutide as CagriSema, and how to track appetite, weight, and tolerability.
Liraglutide: A Tracking Guide for the Daily GLP-1
How to log a liraglutide titration and decide whether the daily-injection tradeoff makes sense for you.
Retatrutide: Tracking a Triple-Agonist Weight-Loss Compound
What Retatrutide is, how the GLP-1 / GIP / glucagon mechanism differs from single-agonists, and how to track titration and side effects honestly.
Ipamorelin and CJC-1295: A Practical Tracking Guide
Two growth-hormone-releasing peptides that are usually used together. How they differ, how protocols are structured, and what to track.
Tirzepatide vs Semaglutide: How to Track the Differences
The two leading GLP-1 protocols compared by what they ask of the user, what to track, and how the side-effect profiles differ across a titration.
Tesamorelin: A Tracking Guide for Visceral-Fat Protocols
What tesamorelin is, how protocols are structured, what to measure if you want to evaluate effects on visceral fat, energy, and sleep.
HGH Fragment 176-191: A Fat-Loss Protocol Tracking Guide
What HGH fragment 176-191 is, why protocols are structured the way they are, and the daily/weekly metrics that actually reveal whether it works for you.